"We are pleased to announce the US Court of Appeals for the Federal Circuit ruling, reversing a district court's finding related to Teva's US patent for Copaxone," Natco said in its filing.
first published: Jul 29, 2013 10:43 am
A collection of the most-viewed Moneycontrol videos.
Live: Nifty extends gain to the second straight day but sees another weekly loss | Closing Bell
Live: Can Nifty extend gains and reclaim 26,000? | Opening Bell
FSS Simply Payments 2025 | AI in Payments: Building a Governance-First Future.
Live: Nifty reclaims 25,900, snaps 3-day losing streak; rupee falls to fresh low | Closing Bell
